Author

Sini Ahonen

University of Turku

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anne JokilammiiD· 1 shared Aura Tuohisto-Kokko· 1 shared Deepankar ChakrobortyiD· 1 shared Iman Khani FarahaniiD· 1 shared Kari J. KurppaiD· 1 shared Klaus EleniusiD· 1 shared Lisa D. EliiD· 1 shared M. S. Johnson· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anne JokilammiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto-Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Khani Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, M. S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa

This study identifies recurrent ERBB4 mutations with oncogenic potential and resistance to targeted therapies, suggesting clinical implications for treatment strategies.

Molecular Oncology · Dec 23, 2025Peer-reviewedCancer Biology